Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fatih Yildiz

Showing results (51-60 of 73) with videos related to

Pageof 8
Sort By:
Anti-Cancer Drugs|July 15, 2021
Does docetaxel matter in metastatic gastric cancer? FOLFOX versus FLOT regimens as first-line treatmentFatih Gürler, Ayşegül İlhan, Deniz Can Güven, et al.
Joint Bone Spine|November 24, 2022
Derivation and validation of adult Still Activity Score (SAS)Umut Kalyoncu, Timuçin Kasifoglu, Ahmet Omma, et al.
Clinical and Experimental Rheumatology|December 3, 2016
Remarkable damage along with poor quality of life in Takayasu arteritis: cross-sectional results of a long-term followed-up multicentre cohortAhmet Omma, Burak Erer, Omer Karadag, et al.
World Journal of Urology|October 28, 2025
Outcomes of retrograde intrarenal surgery in patients on anticoagulant or antiplatelet therapy: a multicenter matched case-control study by the RIRSearch Study GroupMuhammed Fatih Simsekoglu, Oktay Ozman, Mehmet Fatih Sahin, et al.
Clinical and Experimental Rheumatology|February 16, 2019
What are the main barriers to achieve minimal disease activity in psoriatic arthritis in real life?Sibel Bakirci, Dilek Solmaz, Noura Al Osaimi, et al.
The Journal of Arthroplasty|October 23, 2025
2025 ICM: Length of Stay and DischargingFatih Yildiz, Alparslan Uzun, Waleed A Al-Saadan, et al.
Rheumatology (Oxford, England)|July 23, 2013
Impaired quality of life, disability and mental health in Takayasu's arteritisNeslihan Yilmaz, Meryem Can, Fatma Alibaz Oner, et al.
Journal of Cancer Research and Therapeutics|December 17, 2021
Merkel cell carcinoma in Turkey: A multicentric studyFatih Yildiz, Umut Demirci, Ahmet Küçükarda, et al.
Journal of Neuro-Oncology|January 6, 2026
Bevacizumab combined with irinotecan or temozolomide in recurrent glioblastoma: a Turkish Oncology Group (TOG) studySinem Akbas, Ozkan Alan, Oguzhan Yildiz, et al.
The Journal of Rheumatology|July 17, 2015
Incidence of Cyclophosphamide-induced Urotoxicity and Protective Effect of Mesna in Rheumatic DiseasesNeslihan Yilmaz, Hakan Emmungil, Sercan Gucenmez, et al.
Pageof 8

Showing results (51-60 of 73) with videos related to

Sort By:
Pageof 8
Anti-Cancer Drugs|July 15, 2021
Does docetaxel matter in metastatic gastric cancer? FOLFOX versus FLOT regimens as first-line treatmentFatih Gürler, Ayşegül İlhan, Deniz Can Güven, et al.
Joint Bone Spine|November 24, 2022
Derivation and validation of adult Still Activity Score (SAS)Umut Kalyoncu, Timuçin Kasifoglu, Ahmet Omma, et al.
Clinical and Experimental Rheumatology|December 3, 2016
Remarkable damage along with poor quality of life in Takayasu arteritis: cross-sectional results of a long-term followed-up multicentre cohortAhmet Omma, Burak Erer, Omer Karadag, et al.
World Journal of Urology|October 28, 2025
Outcomes of retrograde intrarenal surgery in patients on anticoagulant or antiplatelet therapy: a multicenter matched case-control study by the RIRSearch Study GroupMuhammed Fatih Simsekoglu, Oktay Ozman, Mehmet Fatih Sahin, et al.
Clinical and Experimental Rheumatology|February 16, 2019
What are the main barriers to achieve minimal disease activity in psoriatic arthritis in real life?Sibel Bakirci, Dilek Solmaz, Noura Al Osaimi, et al.
The Journal of Arthroplasty|October 23, 2025
2025 ICM: Length of Stay and DischargingFatih Yildiz, Alparslan Uzun, Waleed A Al-Saadan, et al.
Rheumatology (Oxford, England)|July 23, 2013
Impaired quality of life, disability and mental health in Takayasu's arteritisNeslihan Yilmaz, Meryem Can, Fatma Alibaz Oner, et al.
Journal of Cancer Research and Therapeutics|December 17, 2021
Merkel cell carcinoma in Turkey: A multicentric studyFatih Yildiz, Umut Demirci, Ahmet Küçükarda, et al.
Journal of Neuro-Oncology|January 6, 2026
Bevacizumab combined with irinotecan or temozolomide in recurrent glioblastoma: a Turkish Oncology Group (TOG) studySinem Akbas, Ozkan Alan, Oguzhan Yildiz, et al.
The Journal of Rheumatology|July 17, 2015
Incidence of Cyclophosphamide-induced Urotoxicity and Protective Effect of Mesna in Rheumatic DiseasesNeslihan Yilmaz, Hakan Emmungil, Sercan Gucenmez, et al.
Pageof 8